Not Yet RecruitingNot Applicable

Prognostic Value of the LVOT VTI in STEMI Patients Undergoing PPCI

Egypt125 participantsStarted 2025-08-01

Plain-language summary

* To determine whether LVOT VTI \< 15 cm predicts the development of in-hospital cardiogenic shock or need for vasopressors in STEMI patients undergoing primary PCI. * To assess association of LVOT VTI with other adverse outcomes (in-hospital death, heart failure, arrhythmias, need for mechanical ventilation, prolonged hospital stay).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adult patients (≥18 years), diagnosed with acute STEMI according to current ESC guidelines(3) and undergoing primary PCI within 24 hours of symptom onset.
✓. Patients undergo transthoracic echocardiography within 24 hours of admission.

Exclusion criteria

✕. Presence of significant aortic valve disease (e.g., severe aortic stenosis or regurgitation).
✕. LVOT obstruction or hypertrophic cardiomyopathy.
✕. Poor echocardiographic window.
✕. Refusal to participate.

What they're measuring

Incidence of cardiogenic shock in patients with LVOT VTI < 15 cm

Timeframe: Through hospital stay (up to 3 days)

Trial details

NCT IDNCT07114978

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-08

Contact for this trial

Ahmed Khaled Ahmed Abdel Rahman, Resident doctor

+201144362234 ahmed99khaled8377@gmail.com

View on ClinicalTrials.gov More LVOT VTI trials